Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 15/20 | 0.60 |
| ▸ | KDM5A | P29375 | 5/20 | 0.60 |
| ▸ | KDM2B | Q8NHM5 | 8/20 | 0.57 |
| ▸ | PHF8 | Q9UPP1 | 5/20 | 0.57 |
| ▸ | KDM5B | Q9UGL1 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24244170 | 0.88 | KDM4C (0.61) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL24244247 | 0.86 | KDM4C (0.58) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL24244249 | 0.84 | KDM4C (0.56) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL24244159 | 0.83 | KDM4C (0.68) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL17604553 | 0.76 | KDM4C (0.73) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL24244167 | 0.75 | KDM4C (0.52) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL16034821 | 0.75 | KDM4C (1.00) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL16034379 | 0.74 | PHF8 (0.71) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL17604600 | 0.74 | KDM4C (0.74) | KDM4CKDM5AKDM2BPHF8KDM5B | |
| SCHEMBL17604560 | 0.74 | KDM4C (0.70) | KDM4CKDM5AKDM2BPHF8KDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3436445-B1 | HISTONE DEMETHYLASE INHIBITORS | CELGENE QUANTICEL RES INC (US) | 2023-09-06 | — | — | EP | disclosed |
| EP-3193881-B1 | HISTONE DEMETHYLASE INHIBITORS | CELGENE QUANTICEL RES INC (US) | 2022-02-09 | — | — | EP | disclosed |